Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Non Operating Income (2024 - 2025)

Kairos Pharma's Non Operating Income history spans 2 years, with the latest figure at $34000.0 for Q2 2025.

  • For Q2 2025, Non Operating Income rose 209.68% year-over-year to $34000.0; the TTM value through Jun 2025 reached -$160000.0, changed N/A, while the annual FY2025 figure was $125000.0, 148.08% up from the prior year.
  • Non Operating Income reached $34000.0 in Q2 2025 per KAPA's latest filing, up from $4000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $466000.0 in Q4 2024 to a low of -$664000.0 in Q3 2024.